RNU4ATAC pathogenic variants to date have been associated with microcephalic osteodysplastic primordial dwarfism, type 1 and Roifman syndrome. Both conditions are clinically distinct skeletal dysplasias with microcephalic osteodysplastic primordial dwarfism, type 1 having a more severe phenotype than Roifman syndrome. Some of the overlapping features of the two conditions include developmental delay, microcephaly, and immune deficiency. The features also overlap with Lowry Wood syndrome, another rare but well-defined skeletal dysplasia for which the genetic etiology has not been identified. Characteristic features include multiple epiphyseal dysplasia and microcephaly. Here, we describe three patients with Lowry Wood syndrome with biallelic RNU4ATAC pathogenic variants. This report expands the phenotypic spectrum for biallelic RNU4ATAC disorder causing variants and is the first to establish the genetic cause for Lowry Wood syndrome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774248PMC
http://dx.doi.org/10.1002/ajmg.a.38581DOI Listing

Publication Analysis

Top Keywords

lowry wood
16
wood syndrome
16
rnu4atac pathogenic
12
pathogenic variants
12
microcephalic osteodysplastic
8
osteodysplastic primordial
8
primordial dwarfism
8
dwarfism type
8
roifman syndrome
8
biallelic rnu4atac
8

Similar Publications

Article Synopsis
  • Background: The study focused on the effectiveness of tranexamic acid in preventing bleeding and reducing the need for platelet transfusions in patients with blood cancers receiving intensive treatment.
  • Methods: An international trial (TREATT) involved 616 adults under chemotherapy or stem-cell transplant, who were randomly assigned to receive either tranexamic acid or a placebo while monitored for bleeding and platelet recovery.
  • Findings: Out of 1736 screened patients, 597 were included in the final analysis, revealing demographic details and outcomes related to bleeding events and mortality rates among the two groups.
View Article and Find Full Text PDF

The objective of thermonuclear fusion consists of producing electricity from the coalescence of light nuclei in high temperature plasmas. The most promising route to fusion envisages the confinement of such plasmas with magnetic fields, whose most studied configuration is the tokamak. Disruptions are catastrophic collapses affecting all tokamak devices and one of the main potential showstoppers on the route to a commercial reactor.

View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed data from 115.6 million live births across 15 countries from 2000 to 2020 to assess the prevalence and neonatal mortality rates associated with large for gestational age (LGA) and macrosomia.
  • - Results indicated that LGA babies (those above the 90th percentile) had a lower risk of neonatal mortality compared to appropriate for gestational age (AGA) infants, while overall macrosomia (≥4000 g) also did not show increased mortality risk, except for higher weight categories.
  • - The findings suggest that a birthweight of ≥4500 g is a key indicator for increased early mortality risk in larger infants, which could help inform clinical decisions regarding their care. *
View Article and Find Full Text PDF

Small newborns are vulnerable to mortality and lifelong loss of human capital. Measures of vulnerability previously focused on liveborn low-birthweight (LBW) babies, yet LBW reduction targets are off-track. There are two pathways to LBW, preterm birth and fetal growth restriction (FGR), with the FGR pathway resulting in the baby being small for gestational age (SGA).

View Article and Find Full Text PDF

Objective: To compare neonatal mortality associated with six novel vulnerable newborn types in 125.5 million live births across 15 countries, 2000-2020.

Design: Population-based, multi-country study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!